Salus SALR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 16.78
- Price/Sales
- 0.33
- Dividend Yield (Trailing)
- 3.50%
- Dividend Yield (Forward)
- 3.50%
- Total Yield
- 3.50%
Company Profile
Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Core
- Total Number of Employees
- 582
- Website
- http://www.salus.si
Comparables
Valuation
|
Metric
|
SALR
|
301126
|
600763
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.78 | 25.82 | 34.51 |
Price/Book Value | 2.74 | 1.16 | 6.05 |
Price/Sales | 0.33 | 0.43 | 7.08 |
Price/Cash Flow | 11.07 | 7.17 | 24.20 |
Price/Earnings
SALR
301126
600763
Financial Strength
|
Metric
|
SALR
|
301126
|
600763
|
|---|---|---|---|
Quick Ratio | 0.75 | 0.94 | 1.32 |
Current Ratio | 1.26 | 1.31 | 1.42 |
Interest Coverage | 17.16 | 1.81 | 13.44 |
Quick Ratio
SALR
301126
600763
Profitability
|
Metric
|
SALR
|
301126
|
600763
|
|---|---|---|---|
Return on Assets (Normalized) | 5.53% | 1.61% | 8.36% |
Return on Equity (Normalized) | 15.82% | 4.99% | 13.05% |
Return on Invested Capital (Normalized) | 12.12% | 3.24% | 9.74% |
Return on Assets
SALR
301126
600763
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| Pqgftjf | Rxkkdmg | $63.3 Bil | |||
| Cencora Inc
COR
| Ckqwhnmr | Sqfgfq | $44.1 Bil | |||
| Cardinal Health Inc
CAH
| Kbrczqzt | Zjhhzf | $26.6 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
| — | Cfnbxhb | $9.3 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
| — | Nngffr | $9.3 Bil | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | Zhdwdh | $8.1 Bil | |||
| Sinopharm Group Co Ltd
SHTDF
| — | Ztrzdh | $8.1 Bil | |||
| Amplifon SpA Az nom Post Frazionamento
AMFPF
| — | Qhrpml | $6.7 Bil | |||
| Ebos Group Ltd ADR
EBOSY
| — | Nbxxgr | $4.4 Bil | |||
| Medipal Holdings Corp ADR
MAHLY
| — | Tnvk | $3.6 Bil |
United States